Weichieh Yang

Weichieh Yang

Auto-generated profile, based on publicly available information

Weichieh Yang

Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, 200030, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Journal of Affective Disorders
Verified
Journal Article
Closed access
HHHaijing Huang
Haijing Huang
FWFan Wang
Fan Wang
YCYiming Chen
Yiming Chen
SKShuqi Kong
Shuqi Kong
QHQinte Huang
Qinte Huang
WHWu Hong
Wu Hong

2 November 2023 in Psychiatry Research
Verified
Journal Article
Open access
YCYiming Chen
Yiming Chen
CWChenglin Wu
Chenglin Wu
DLDongbin Lyu
Dongbin Lyu
FWFan Wang
Fan Wang
QHQinte Huang
Qinte Huang
WHWu Hong
Wu Hong
We investigated whether changes through doubling the duration of each tDCS session would increase efficacy of tDCS for depression. tDCS was applied for 10 sessions, followed by two additional weekly sessions. 63 patients with MDD underwent randomization, with 22 being assigned to 60-min/d group, 25 to 30 min/d group, and 16 to sham group. HAMD-17 reductive ratios at week 2 and 4 were of no significant differences among treatment groups. 60 min group had a greater decrease in anxiety compared to 30 min group and sham group based on HAMA at 4 weeks but only in the completer analysis, not in ITT analysis.

14 October 2023 in Journal of Psychiatric Research
Verified
Journal Article
Closed access
HHHaijing Huang
Haijing Huang
YCYiming Chen
Yiming Chen
SKShuqi Kong
Shuqi Kong
MZMengke Zhang
Mengke Zhang
CWChenglin Wu
Chenglin Wu
WHWu Hong
Wu Hong

19 December 2022 in BMC Psychiatry
Verified
Journal Article
Open access
PDF file
YCYiming Chen
Yiming Chen
DLDongbin Lyu
Dongbin Lyu
FWFan Wang
Fan Wang
QHQinte Huang
Qinte Huang
WYWeichieh Yang
Weichieh Yang
WHWu Hong
Wu Hong
Background: Treatment-resistant depression (TRD) carries a high economic burden worldwide. Transcranial direct current stimulation (tDCS) is advantageous for improving cognition and can be safely used in the treatment of depression. The effectiveness of tDCS of the left and right orbitofrontal cortex (OFC) as adjuvant treatment in patients with TRD has rarely been explored. Therefore, the objective of this trial is to evaluate the effectiveness there of when administering left dorsolateral prefrontal cortex (DLPFC) positive stimulation or OFC negative stimulation in patients with TRD. Methods: Ninety eligible participants will be recruited to receive intervention at Shanghai Mental Health Center. Treatment will be randomly assigned in a double-blind fashion. Participants will receive either DLPFC (n = 30), OFC (n = 30), or sham (n = 30) tDCS, while continuing their usual pharmacotherapy at a stable dosage for at least 2 weeks before enrollment and throughout the stimulation period. All participants will receive 20 weekday stimulation sessions of 60 minutes duration each. Participants in the active group will be stimulated at 2 mA throughout the session, whereas the sham group will receive only a brief period of stimulation to mimic the sensation. After 20 stimulation sessions, no further treatment will be administered. Measurements will be conducted at regular points throughout and at 8 weeks after trial completion. The primary outcome is the change in the 17-item Hamilton Depression Rating Scale (HAMD-17) score after 20 sessions. Secondary outcomes were defined as changes in other measurement scales, cognitive function, resting-state functional magnetic resonance imaging (rs-fMRI), and serum biomarkers. Discussion: We hypothesize that, in contrast to the sham group, both the active DLPFC and OFC tDCS groups will show superiority in HAMD-17 score reduction after 5, 10, and 20 sessions. Moreover, associations of the improvement of depressive symptoms with variations in rs-fMRI and TRD-related biomarkers will be evaluated. Our study may suggest that adjunctive intensive tDCS with left DLPFC positive stimulation or right OFC negative stimulation may be effective as a novel method to relieve depressive symptoms in patients with TRD. The variation of rs-fMRI, biomarkers could be used as a potential prediction model of treatment efficacy in TRD. Trial registration: The trial protocol is registered with www.chictr.org.cn under protocol registration number ChiCTR2200058030. Date of registration: March 27, 2022. Recruitment started in September 2022 and is ongoing.

8 November 2024 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
SSShuxiang Shi
Shuxiang Shi
HHHaijing Huang
Haijing Huang
MZMengke Zhang
Mengke Zhang
YCYiming Chen
Yiming Chen
WYWeichieh Yang
Weichieh Yang
WHWu Hong
Wu Hong
Aim: There is a lack of research on transcranial direct current stimulation (tDCS) for the treatment of somatic symptoms in major depressive disorder (MDD) and the suitable stimulating brain region. We investigated the efficacy of tDCS targeting the dorsolateral prefrontal cortex (DLPFC) versus orbitofrontal cortex (OFC) on depressive somatic symptoms and somatic anxiety in patients with MDD and aimed to identify the appropriate stimulating brain regions.Methods: In this randomized, double‐blind, sham‐controlled study, a total of 70 patients diagnosed with MDD were randomly allocated into DLPFC group, OFC group, and Sham group. Subjects participated in 2 weeks of 10 primary interventions and subsequently 2‐week maintenance interventions weekly (20 min, 2 mA).Results: The DLPFC group showed a more significant improvement in somatic symptoms compared to the Sham group at week 2. At the maintenance and follow‐up stages, the DLPFC group outperformed the Sham and OFC groups, but the difference with the Sham group was not significant. Neither active group demonstrated superiority over the Sham group in improving depression and anxiety.Conclusion: In conclusion, the tDCS targeting DLPFC may be a potentially effective therapeutic target for alleviating somatic symptoms in patients with MDD.

11 July 2023 in Journal of Psychiatric Research
Verified
Journal Article
Closed access
CXChuchen Xu
Chuchen Xu
FWFan Wang
Fan Wang
QHQinte Huang
Qinte Huang
DLDongbin Lyu
Dongbin Lyu
CWChenglin Wu
Chenglin Wu
WHWu Hong
Wu Hong